Advisory Services Network’s Invesco Pharmaceuticals ETF PJP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-165
| Closed | -$17.1K | – | 3960 |
|
|
2026
Q1 | $17.1K | Buy |
+165
| New | +$17.4K | ﹤0.01% | 3287 |
|
|
2025
Q4 | – | Sell |
-165
| Closed | -$15.3K | – | 3594 |
|
|
2025
Q3 | $15.3K | Buy |
+165
| New | +$14.4K | ﹤0.01% | 3083 |
|
|
2024
Q1 | – | Sell |
-255
| Closed | -$19.4K | – | 3058 |
|
|
2023
Q4 | $19.4K | Buy |
+255
| New | +$18.2K | ﹤0.01% | 2548 |
|
|
2023
Q2 | – | Sell |
-412
| Closed | -$31.3K | – | 3044 |
|
|
2023
Q1 | $31.3K | Hold |
412
| – | – | ﹤0.01% | 2268 |
|
|
2022
Q4 | $32.3K | Buy |
+412
| New | +$31.7K | ﹤0.01% | 2197 |
|
|
2021
Q3 | – | Sell |
-1,301
| Closed | -$105K | – | 2726 |
|
|
2021
Q2 | $105K | Buy |
+1,301
| New | +$103K | ﹤0.01% | 1584 |
|
|
2021
Q1 | – | Sell |
-1,301
| Closed | -$93K | – | 2510 |
|
|
2020
Q4 | $93K | Sell |
1,301
-1,000
| -43% | -$66.9K | ﹤0.01% | 1360 |
|
|
2020
Q3 | $147K | Buy |
+2,301
| New | +$150K | 0.01% | 1088 |
|
|
2020
Q2 | – | Sell |
-1,756
| Closed | -$97K | – | 2275 |
|
|
2020
Q1 | $97K | Sell |
1,756
-585
| -25% | -$35.6K | 0.01% | 1087 |
|
|
2019
Q4 | $152K | Sell |
2,341
-246
| -10% | -$15K | 0.01% | 992 |
|
|
2019
Q3 | $156K | Hold |
2,587
| – | – | 0.01% | 907 |
|
|
2019
Q2 | $156K | Buy |
2,587
+2,137
| +475% | +$131K | 0.01% | 905 |
|
|
2019
Q1 | $29K | Hold |
450
| – | – | ﹤0.01% | 1458 |
|
|
2018
Q4 | $28K | Hold |
450
| – | – | ﹤0.01% | 1364 |
|
|
2018
Q3 | $33K | Hold |
450
| – | – | ﹤0.01% | 1379 |
|
|
2018
Q2 | $32K | Hold |
450
| – | – | ﹤0.01% | 1370 |
|
|
2018
Q1 | $28K | Hold |
450
| – | – | ﹤0.01% | 1520 |
|
|
2017
Q4 | $29K | Hold |
450
| – | – | ﹤0.01% | 1491 |
|
|
2017
Q3 | $29K | Hold |
450
| – | – | ﹤0.01% | 1290 |
|
|
2017
Q2 | $28K | Sell |
450
-101
| -18% | -$6.06K | ﹤0.01% | 1236 |
|
|
2017
Q1 | $32K | Buy |
+551
| New | +$32.2K | ﹤0.01% | 1125 |
|
|
2016
Q3 | $65K | Buy |
1,054
+2
| +0.2% | +$131 | 0.01% | 796 |
|
|
2016
Q2 | $67K | Sell |
1,052
-108
| -9% | -$6.79K | 0.02% | 714 |
|
|
2016
Q1 | $70K | Buy |
1,160
+31
| +3% | +$1.9K | 0.02% | 581 |
|
|
2015
Q4 | $79K | Hold |
1,129
| – | – | 0.03% | 488 |
|
|
2015
Q3 | $75K | Buy |
1,129
+88
| +8% | +$6.85K | 0.02% | 456 |
|
|
2015
Q2 | $82K | Buy |
1,041
+382
| +58% | +$29.7K | 0.02% | 420 |
|
|
2015
Q1 | $50K | Hold |
659
| – | – | 0.01% | 494 |
|
|
2014
Q4 | $46K | Buy |
+659
| New | +$43.9K | 0.01% | 440 |
|
|
2014
Q1 | – | Sell |
-100
| Closed | -$5K | – | 651 |
|
|
2013
Q4 | $5K | Buy |
+100
| New | +$5K | ﹤0.01% | 803 |
|
Other funds holding PJP
PAM
JGCM
Advisory Services Network's PJP Position: Q2 2026 in Review
Advisory Services Network sold out of Invesco Pharmaceuticals ETF (PJP) in Q2 2026, closing a stake of 165 shares — an estimated $17.1K sold.
Advisory Services Network first reported a position in PJP in Q4 2013 and held it in 30 quarters. The position peaked at $156K in Q3 2019. 117 funds tracked by Wall St. Rank hold PJP as of Q2 2026.
- Advisory Services Network reported no remaining Invesco Pharmaceuticals ETF position as of Q2 2026 after selling out during the quarter.
- Advisory Services Network sold 165 Invesco Pharmaceuticals ETF shares in Q2 2026, an estimated $17.1K.
- Advisory Services Network first reported a position in Invesco Pharmaceuticals ETF in Q4 2013 and held it in 30 quarters.
- Advisory Services Network's Invesco Pharmaceuticals ETF position peaked at $156K in Q3 2019.
- 117 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.
Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.